Acotec Scientific Holdings has a quick ratio of 9.12. It generally indicates good short-term financial strength.
The historical rank and industry rank for Acotec Scientific Holdings's Quick Ratio or its related term are showing as below:
HKSE:06669'
s Quick Ratio Range Over the Past 10 Years
Min: 0.47 Med: 9.12 Max: 13.64
Current: 9.12
During the past 5 years, Acotec Scientific Holdings's highest Quick Ratio was 13.64. The lowest was 0.47. And the median was 9.12.
HKSE:06669's Quick Ratio is ranked better than 90.46% of 870
companies
in the Medical Devices & Instruments industry
Industry Median: 2.035
vs HKSE:06669: 9.12
Acotec Scientific Holdings Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Acotec Scientific Holdings's Quick Ratio
For the Medical Devices subindustry, Acotec Scientific Holdings's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acotec Scientific Holdings's Quick Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Acotec Scientific Holdings's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Acotec Scientific Holdings's Quick Ratio falls into.
Acotec Scientific Holdings Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acotec Scientific Holdings (HKSE:06669) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Acotec Scientific Holdings Quick Ratio Related Terms
Thank you for viewing the detailed overview of Acotec Scientific Holdings's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Acotec Scientific Holdings (HKSE:06669) Business Description
Acotec Scientific Holdings Ltd is a medical device company. The company is focused on providing leave nothing behind treatment solutions for vascular diseases. It has developed a suite of interventional medical devices featuring world- leading technologies, notably in the fields of drug-coated balloons and thrombus aspiration catheters. The company's commercialized product is Semi-compliant PTCA Balloon (YAN) is a product designed for dilation in coronary artery or coronary artery bypass vessels stenosis to improve myocardial perfusion. Geographically, the company operates from Mainland China, Europe and Other countries and regions. Majority of revenue is generated from Mainland China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06669 has been successfully added to your 